Navarre Corp (NAVR:NASDAQ) is a publisher and distributor of physical and digital home entertainment and multimedia products in the U.S. and Canada. The company’s customers come from a wide spectrum of retailers, including mass merchandisers, third party distributors, wholesale clubs, … Continue reading →

Generex Biotechnology Corp. (Nasdaq: GNBT) is a leader in drug delivery for metabolic diseases through the inner lining of the mouth. The company has developed a proprietary Metformin chewing gum product, MetControl. Today, the company announced it produced clinical samples … Continue reading →

A few years ago, as a wedding gift of sorts, one of our writer’s friends was presented with stock in Advanced Micro Devices Inc. (AMD). Since that time, he has watched his stock plummet from over $40 a share to … Continue reading →

You can’t blame Spire Corp. for basking in the sunshine of success when it comes to their business. As a leading provider of products and services to the solar energy, biomedical, and optoelectronics industries, they seek to provide innovative products … Continue reading →

In this information age, Learning Tree International (LTRE) knows the importance of specialized training for business professionals. Their focus is on helping IT and other professionals in public and private sector businesses stay at the forefront of knowledge in their … Continue reading →

Manny, Moe & Jack of the Pep Boys (PBY) gave their former chief executive a compensation package worth $17.2 million for just over 10 months of work in 2007, but he had to forfeit 39% of it this year after … Continue reading →

This small capital stock from the Trucking Industry of the Transportation Sector proves that the Process element of the Services Marketing Mix can be honed in to a sustainable competitive advantage. The company covers all of North America from its … Continue reading →

Disposable products have essential roles in modern healthcare. The core strength of this small capital member of the Medical Equipment & Supplies Industry from Hauppauge, NY is that each of its six lines of revenue enjoys relatively stable demand regardless … Continue reading →

An arm of the U.S. Department of Health and Human Services has granted the company $2 million for a two-year program to develop its technology related to the management of sexually transmitted diseases. This company also has licensing and collaboration … Continue reading →

StemCells, Inc. (NASDAQ:STEM), a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell-based therapeutics to treat diseases of the central nervous system and liver, recently announced the company’s support of the National Neurotechnology Inititative Act, an initiative … Continue reading →